ClinicalThought

Share

Program Content

Activities

  • Using TRK Inhibitors
    How I Use TRK Inhibitors in Patients With NTRK Fusion–Positive Tumors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 10, 2020

    Expires: July 09, 2021

Faculty

cover img faculity

Alexander E. Drilon, MD

Chief, Early Drug Development Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Bayer Healthcare Pharma

Genentech TEXT Only